Inbec 30 mg (Abacavir/Dolutegravir/Lamivudine)

Inbec 30 mg is a powerful once-daily HIV treatment combining Dolutegravir, Abacavir, and Lamivudine to effectively suppress HIV and support immune recovery.

pack size Price Add to Cart
30 Tablets - USD $3.83 Per Tablet$115.00
View Cart
60 Tablets - USD $3.50Per Tablet$210.00
View Cart
90 Tablets - USD $3.28 Per Tablet$295.00
View Cart

Inbec 30 mg (Abacavir/Dolutegravir/Lamivudine)

Active IngredientAbacavir/Dolutegravir/Lamivudine
Manufacturer:Emcure Pharmaceuticals Ltd.
Indication:HIV infection
Packaging30 Tablets in bottle
Strength30mg
Delivery Time6 To 15 days

Inbec 30 mg is a once-daily fixed-dose combination antiretroviral tablet containing Abacavir, Dolutegravir, and Lamivudine. It is used in the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg. This single-tablet regimen simplifies HIV management by combining three powerful agents with complementary actions that reduce viral replication and improve immune function.


Key Ingredients & Their Functions:

  • Dolutegravir (30 mg): An integrase strand transfer inhibitor (INSTI) that blocks the integration of viral DNA into host DNA.

  • Abacavir (600 mg): A nucleoside reverse transcriptase inhibitor (NRTI) that stops the reverse transcription of viral RNA into DNA.

  • Lamivudine (300 mg): Another NRTI that also targets the reverse transcriptase enzyme to prevent viral replication.

pack size

30 Tablets – USD $3.83 Per Tablet, 60 Tablets – USD $3.50Per Tablet, 90 Tablets – USD $3.28 Per Tablet

There are no reviews yet.

Be the first to review “Inbec 30 mg (Abacavir/Dolutegravir/Lamivudine)”